Local News: Denver, CO 

 | 

Sign Up

 | 

Sign In

Advertisment

SkyePharma News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make SkyePharma News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

SkyePharma News

News on SkyePharma continually updated from thousands of sources around the net.

Nov 18, 2009 | Market Wire

Skyepharma PLC - Board Change

CHAIRMAN LONDON, UK, 18 November, 2009 - SkyePharma PLC regrets to announce today that its Chairman, Jeremy Scudamore, has informed the Board that he intends to step down from the Board at the end of 2009 for health reasons.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Nov 02, 2009

Earth Times

Flutiform EU Clinical Trial Successfully Completed

FOR IMMEDIATE RELEASE SkyePharma Announces Successful Completion of FlutiformTM EU Clinical Trial Programme LONDON, UK, 2 November, 2009 - SkyePharma PLC today announces that its development and marketing partner Mundipharma International Corporation Limited has successfully completed the final Phase III clinical study for the European development ...

Comment?

Related Topix: Biotech, Marketing, Medicine, Asthma, Health, Foradil, Formoterol (generic), Medication, Fluticasone (generic), Flovent

Tue Sep 01, 2009

Market Wire

Skyepharma PLC - Research Update

Flutiform U.S. Filing Update LONDON, UK, 1 September 2009 - SkyePharma PLC today provides an update following a meeting held with the US Food and Drug Administration to discuss the previously announced potential review issues in respect of the New Drug Application for its lead development product, Flutiform , an investigational treatment for ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Foradil, Formoterol (generic), Medication, Fluticasone (generic), Flovent, Asthma, Health

Wed Jun 10, 2009

OfficialWire

FDA Calendar Updates: Par Pharma (NYSE: PRX), Watson Pharma...

FDA Calendar Updates: Par Pharma , Watson Pharma , NeurogesX , And Trinity Biotech Trinity Biotech awaiting two responses from FDA Published on June 10, 2009 by Mike Havrilla, BioMedReports LOS ANGELES, CA Below is a summary of updates to the BioMedReports.com FDA Calendar , which includes a database of over 200 entries.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Pharmaceutical Resources, Startups, NeurogesX, Trinity Biotech, Asthma, Health

Denver Jobs

Also on Topix